Novartis Investigative Site is a clinical research site located in Mobile, Alabama, United States 36617.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Novartis Investigative Site has participated in 35 clinical trials with 1 currently active.
Therapeutic areas: Organ Transplantation, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD).
Sponsors: Novartis Pharmaceuticals, Novartis.
Trust Score: 77/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Novartis Investigative Site has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novartis Investigative Site has 35 clinical trials on record, with 1 currently active. Their work covers Organ Transplantation, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD).
Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.